Boardroom Alpha
Boardroom Alpha
DCGO · Additional Proxy Materials (DEFA14A) · Filed April 22, 2026

Docgo Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 22, 2026
Ticker
DCGO
Accession
0001213900-26-046603
Boardroom Alpha · Filing insights

DocGo seeks stockholder votes on directors, executive pay, six reverse-split options, governance amendments, officer-liability limit, and auditor appointment; board recommends For.

About Docgo Inc
Market cap
$38M
1Y TSR
−62.7%
3Y TSR
−60.3%
Board grade
C-
Sector
Healthcare
CEO
Lee Bienstock
Last annual meeting: Jun 16, 2026 · View full Docgo Inc profile →

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

________________

SCHEDULE 14A

________________

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.    )

Filed by the Registrant

 

Filed by a Party other than the Registrant

 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under §240.14a-12

DocGo Inc.

(Name of Registrant as Specified in Its Charter)

________________________________________________________________

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

  

 

*Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V94318-P42749 DOCGO INC. 685 THIRD AVENUE, 9TH FLOOR NEW YORK, NY 10017 Your Vote Counts! DOCGO INC. 2026 Annual Meeting Vote by June 15, 2026 11:59 PM ET You invested in DOCGO INC. and it’s time to vote! You have the right to vote on the proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the Annual Meeting of Stockholders to be held on June 16, 2026. Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the materials by requesting prior to June 2, 2026. If you would like to request a copy of the proxy materials for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. There is no charge for requesting a paper or emailed copy of the proxy materials. Vote Virtually at the Meeting* June 16, 2026 12:00 PM ET Virtually at: www.virtualshareholdermeeting.com/DCGO2026a

 

Vote at www.ProxyVote.com Voting Items Board Recommends V94319-P42749 THIS IS NOT A VOTABLE BALLOT This is an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials at www.proxyvote.com or easily request a paper or emailed copy. We encourage you to access and review all of the important information contained in the proxy materials before voting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of Directors Class II Nominees: For 01) Vina Leite 02) James M. Travers 2. To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers. For 3. To approve a series of six alternative amendments to the Company’s Second Amended and Restated Certificate of Incorporation to effect (i) a reverse stock split of the Company’s common stock at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 (each, a “Reverse Stock Split”), with such ratio and the time of the Reverse Stock Split as determined in the sole discretion of the Company’s Board of Directors at a later date, and (ii) a proportionate reduction in the number of authorized shares of the Company’s common stock and preferred stock by a corresponding ratio. For 4. To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation regarding the waiver of corporate opportunities. For 5. To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. For 6. Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026. For NOTE: Such other business as may properly come before the meeting or any adjournment or postponement thereof.

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Docgo Inc (DCGO)

Reference

Frequently asked questions

When did Docgo Inc file this DEFA14A?
Docgo Inc (DCGO) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 22, 2026. The accession number assigned by EDGAR is 0001213900-26-046603.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
DocGo seeks stockholder votes on directors, executive pay, six reverse-split options, governance amendments, officer-liability limit, and auditor appointment; board recommends For. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Docgo Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Docgo Inc has filed under CIK 1822359, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer